Alternative potentials for the treatment of pneumocystic pneumonia in case of intolerance to trimethoprim/sulfamethoxazole: clinical observation of rare complication of immunosuppressive therapy in Takayasu arteritis
- Autores: Novikov P.I1, Smirnova E.V1, Vinogradova E.S1,2, Kulikov A.N1, Moiseev S.V1,2
-
Afiliações:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Lomonosov Moscow State University
- Edição: Nº 2S (2018)
- Páginas: 68-71
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/296532
- DOI: https://doi.org/10.18565/pharmateca.2018.s2.68-71
- ID: 296532
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
P. Novikov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: novikov-pavel@mail.ru
PhD, Head of Rheumatological department № 1 UCH № 3
E. Smirnova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
E. Vinogradova
I.M. Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
A. Kulikov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
S. Moiseev
I.M. Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
Bibliografia
- Safrin S., Finkelstein D.M., Feinberg J., et al. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim and clindamycinprimaquine. ACTG 108 Study Group. Ann. Intern. Med. 1996;124(9):792-802.
- Estrada S., Garda-Campos F., Calderon R., et al. Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis. Inflamm. Bowel. Dis. 2009;15(2):315-16.
- Ceballos M.E., Ortega M., Andresen M., et al. Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jiroveci pneumonia. AIDS. 2011;25(17):2192-93.
- Chen M., Tian X., Qin F., et al. Pneumocystis pneumonia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death. PLoS One. 2015;10(9):e0139144.
- Patel S., et al. Pneumocystis jiroveci pneumonia in a patients with systemic lupus erythematosus. Am. J. Respir. Crit. Care Med. 2016;193;A7136.
- Chew L.C., Maceda-Galang L.M., Tan Y.K., et al. Pneumocystis jiroveci pneumonia in a patients with autoimmune diseases on high-doseglucocorticoid. J. Clin. Rheumatol. 2015;21(2):72-5.
- Li Y., Ghannoum M., Deng C., et al. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping Int. J. Infect. Dis. 2017;57:108-15.
- Norris A., Norris K.A., et al. Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 2012;25(2):297-317.
Arquivos suplementares
![](/img/style/loading.gif)